SEC Form 4 · accession 0001225208-15-016754

Neurogene Inc. · NGNE

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

PFIZER INC

10% Owner

Period of report

Aug 10, 2015

Accepted (ET)

Aug 12, 2015 · 4:30 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001404644

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Aug 10, 2015	S	18	$29.00	D	1,235,312	D
Common Stock^F1	Aug 10, 2015	S	2,840	$41.2475	D	1,232,472	D
Common Stock^F2	Aug 10, 2015	S	2,975	$28.467	D	1,229,497	D
Common Stock^F3	Aug 10, 2015	S	3,207	$35.6072	D	1,226,290	D
Common Stock^F4	Aug 10, 2015	S	6,073	$40.2955	D	1,220,217	D
Common Stock^F5	Aug 10, 2015	S	8,565	$27.3561	D	1,211,652	D
Common Stock^F6	Aug 10, 2015	S	8,969	$21.4506	D	1,202,683	D
Common Stock^F7	Aug 10, 2015	S	9,142	$39.5172	D	1,193,541	D
Common Stock^F8	Aug 10, 2015	S	9,901	$37.2264	D	1,183,640	D
Common Stock^F9	Aug 10, 2015	S	10,544	$36.3687	D	1,173,096	D
Common Stock^F10	Aug 10, 2015	S	11,627	$38.4947	D	1,161,469	D
Common Stock^F11	Aug 10, 2015	S	12,726	$25.3233	D	1,148,743	D
Common Stock^F12	Aug 10, 2015	S	13,109	$26.3213	D	1,135,634	D
Common Stock^F13	Aug 10, 2015	S	25,931	$20.3476	D	1,109,703	D
Common Stock^F14	Aug 10, 2015	S	31,400	$24.3129	D	1,078,303	D
Common Stock^F15	Aug 10, 2015	S	44,268	$22.5994	D	1,034,035	D
Common Stock^F16	Aug 10, 2015	S	58,632	$23.4112	D	975,403	D

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses

F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.00 to $41.46, inclusive. The reporting person undertakes to provide to Aquinox Pharmaceuticals Inc., the "Issuer", any security holder of the Issuer, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes (1) through (16) to this Form 4.
F10The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.00 to $38.93, inclusive.
F11The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.99, inclusive.
F12The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.00 to $26.99, inclusive.
F13The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.82, inclusive.
F14The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.00 to $24.90, inclusive.
F15The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.00 to $22.98, inclusive.
F16The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.00 to $23.99, inclusive.
F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.00 to $28.90, inclusive.
F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.25 to $35.94, inclusive.
F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.99, inclusive.
F5The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.00 to $27.90, inclusive.
F6The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.01 to $21.87, inclusive.
F7The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.00 to $39.99, inclusive.
F8The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.00 to $37.90, inclusive.
F9The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.00 to $36.99, inclusive.